The risk of subsequent osteoporotic fractures is decreased in subjects experiencing fracture while on denosumab: results from the FREEDOM and FREEDOM Extension studies

Author(s):
Kendler, D.L.; Chines, A.; Brandi, M.L.; Papapoulos, S.; Lewiecki, E.M.; Reginster, J.Y.; Torres, M.M.; Wang, A.; Bone, H.G.
Published
2019
Publication type
Article / Letter to editor
DenosumabFractureOsteoporosisSubsequent fracture
Date issued
2019-01-31
Language
English
Is part of
Osteoporosis International (2019), Vol. 30, no. 1, p. 71-78
hdl
1887/119670
doi
10.1007/s00198-018-4687-2